MYOS RENS

MYOS NASDAQ
1.530
+0.002
+0.16%
Closed 16:00 08/16 EDT
Open
1.508
Prev Close
1.528
High
1.562
Low
1.508
Volume
743
Avg Vol (3M)
26.00K
52 Week High
2.020
52 Week Low
1.040
% Turnover
0.01%
Market Cap
14.03M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers MYOS RENS MYOS stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

MYOS RENS Technology Inc. (MYOS), formerly MYOS Corporation, is an early-stage bionutrition and biotherapeutics company. The Company is focused on the discovery, development and commercialization of products that improve muscle health and function essential for the management of sarcopenia, cachexia and degenerative muscle diseases, and as an adjunct to the treatment of obesity. The Company is focused on the discovery, development, and commercialization of nutritional supplements, functional foods, therapeutic products, and other technologies for maintaining the health and performance of muscle tissue. MYOS is evaluating the modulation of myostatin. Its research is focused on developing strategies and therapeutic interventions to address muscle related conditions, including sarcopenia, cachexia, and inherited and acquired muscle diseases. The Company, through its subsidiary, holds the intellectual property pertaining to Fortetropin, which is a dietary supplement.
MORE >

Recently

Name
Price
%Change